William H Polonsky

Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

Philip Home, Irl B Hirsch, Oliver Schnell, 2017, Diabetes technology & therapeutics.

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

W. Polonsky, R. Henry, William H Polonsky, 2016, Patient preference and adherence.

Physician-patient communication at prescription of an additional oral drug for type 2 diabetes and its links to patient outcomes - New findings from the global IntroDia® study.

Victoria Gamerman, William H Polonsky, Anne Belton, 2019, Diabetes research and clinical practice.

Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program.

Richard A Jackson, W. Polonsky, J. Earles, 2003, Diabetes care.

Physician-patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia® study.

Victoria Gamerman, W. Polonsky, S. Edelman, 2017, Diabetes research and clinical practice.

A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.

Christopher G Parkin, W. Polonsky, L. Fisher, 2011, Diabetes technology & therapeutics.

Assessment of Diabetes-Related Distress

Garry Welch, Carolyn E Schwartz, B. Anderson, 1995, Diabetes Care.

Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes.

Christopher G Parkin, W. Polonsky, C. Parkin, 2009, Diabetes technology & therapeutics.